Phase 2 trial of talabostat in stage IV melanoma.

被引：0
作者：
Redman, BG
Ernstoff, MS
Gajewski, TF
Cunningham, C
Lawson, DH
Gregoire, L
Haltom, E
Uprichard, MJ
机构：
[1] Univ Michigan, Comp Canc Ctr, Ann Arbor, MI 48109 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Univ Chicago, Chicago, IL 60637 USA
[4] Mary Crowley Med Res Ctr, Dallas, TX USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Point Therapeut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：727S / 727S
页数：1
相关论文
共 50 条
[31]   A phase 2 trial of neoadjuvant biochemotherapy in stage 3 melanoma [J].
Gibbs, P ;
Anderson, C ;
Pearlman, N ;
Becker, M ;
O'Driscoll, M ;
Stephens, J ;
Baron, A ;
Gonzalez, R .
INTERNATIONAL JOURNAL OF CANCER, 2002, :407-407
[32]   Immunological results of a phase II randomized trial of multipeptide vaccines for melanoma. [J].
Slingluff, CL ;
Petroni, G ;
Bullock, KA ;
Bissonnette, E ;
Hibbitts, S ;
Murphy, C ;
Anderson, N ;
Grosh, WW ;
Neese, PY ;
Fink, R .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :710S-710S
[33]   A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma. [J].
Trefzer, U ;
Weingart, G ;
Adrian, K ;
Chen, Y ;
Guo, YJ ;
Audring, H ;
Winter, H ;
Walden, P ;
Sterry, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) :404-404
[34]   Phase II trial of extended-dosing temozolomide in patients with melanoma. [J].
Rietschel, P. ;
Ejadi, S. ;
Wolchok, J. ;
Krown, S. ;
Gerst, S. ;
Jungbluth, A. A. ;
Busam, K. ;
Smith, K. ;
Panageas, K. ;
Chapman, P. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :463S-463S
[35]   Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma. [J].
Taylor, Matthew H. ;
Vogelzang, Nicholas J. ;
Cohn, Allen Lee ;
Stepan, Daniel E. ;
Shumaker, Robert Charles ;
Dutcus, Corina E. ;
Guo, Matthew ;
Schmidt, Emmett V. ;
Rasco, Drew W. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
[36]   A Phase 2 Trial of Complete Resection for Stage IV Melanoma Results of Southwest Oncology Group Clinical Trial S9430 [J].
Ollila, David W. .
CANCER, 2011, 117 (20) :4579-4581
[37]   Phase I trial of extended-dose anti-PD-1 antibody BMS-936558 with a multipeptide vaccine for previously treated stage IV melanoma. [J].
Kudchadkar, Ragini Reiney ;
Gallenstein, Donna ;
Martinez, Alberto J. ;
Yu, Bin ;
Weber, Jeffrey S. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[38]   Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma. [J].
Hwu, WJ ;
Coit, D ;
Jaques, D ;
Panageas, KS ;
Lamb, LA ;
Quinn, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :728S-728S
[39]   Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma. [J].
Bystryn, JC ;
Oratz, R ;
Shapiro, R ;
Harris, M ;
Roses, D ;
Jacquotte, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) :498-498
[40]   Phase II study of HSPPC-96 in combination with GM-CSF and IFN-α in stage IV malignant melanoma. [J].
Parmiani, G .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :712S-712S
12345